Intesti-bacteriophage (Intesti-bacteriofag)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsp
Solution for oral and rectal administration.
Composition:
The preparation is a mixture of sterile filtrates filiglates Shigella flexneri 1, 2, 3, 4, 6 serovars, Shigella sonnei, Salmonella paratyphi A, Salmonella paratyphi B, Salmonella typhimurium, Salmonella infantis, Salmonella choleraesuis, Salmonella oranienburg, Salmonella enteritidis, Enteropathogenic Escherichia coli of various serogroups, the most significant in the etiology of enteric diseases, Proteus vulgaris, Proteus mirabilis, Enterococcus, Staphylococcus, Pseudomonas aeruginosa. Auxiliary substance: preservative - quinazole - 0,0001 g / ml.

Description:
It is a transparent liquid of yellow color of varying intensity, a greenish shade is allowed.

Biological properties. The preparation causes a specific lysis of S. flexneri bacteria 1, 2, 3, 4, 6 serovarians, S. sonnei, S.paratyphi A, S.paratyphi B, S. typhymurium, S.infantis, S. choleraesuis, S.oranienburg, S .enteritidis, E. coli, P. vulgaris, P.mirabilis, Enterococcus, Staphylococcus, P. aeruginosa.

Pharmacotherapeutic group:MIBP bacteriophage.
ATX: & nbsp
  • Other different drugs
    • Pharmacodynamics:

    Indications:
    Treatment and prevention of diseases of the gastrointestinal tract caused by dysentery bacteria, salmonella, coliculus escherichia, proteus, enterococci, staphylococcus, pseudomonas aeruginosis, or a combination thereof.

    - bacterial dysentery;

    - salmonellosis;

    - dyspepsia;

    - dysbiosis;

    - enterocolitis, colitis.

    An important condition for effective phage therapy is the preliminary determination of the pathogenicity of the pathogen.
    Contraindications:Hypersensitivity to the drug components
    Pregnancy and lactation:
    The use of this medication during pregnancy and during breast-feeding is possible in the presence of infections caused by phagosensitive strains of bacteria (on the recommendation of a doctor).

    Dosing and Administration:
    The drug is intended for oral and rectal administration. For treatment, the drug is taken orally 4 times a day for 0.5-1 h before meals from the first day of the disease for 7-10 days.

    Babies first months of life in the first two days of reception preparation diluted boiled water twice, in the absence of side effects (vomiting, rashes on the skin) can then be applied undiluted bacteriophage. The drug is administered through the mouth 3 times a day for 30 minutes before feeding. In cases of indomitable vomiting, the drug is used in the form of high enemas (through a gas outlet tube or catheter) daily. A combination of rectal (in the form of high enemas) and oral administration of the drug is possible. The course of treatment is 7-10 days.

    Recommended dosage of the drug

    ATozast

    Dose for 1 admission (ml)

    orally

    rectally

    0-6 months.

    5

    10

    6-12 months.

    10-15

    20

    from 1 year to 3 years

    15-20

    20-30

    from 3 to 8 years

    20-30

    30-40

    from 8 years and older

    30-40

    50-60

    In the absence of a colitis syndrome, it is recommended to replace one ingestion with one single rectal administration of a single age dose of the drug in the form of an enema after bowel emptying.

    In prophylactic purposes the optimal scheme of use is a daily intake of a single age-related dose. The duration of the drug is determined by the conditions of the epidemiological situation.

    Precautions for use. In case of turbidity, do not use the drug!

    Due to the content of the nutrient medium in which the bacteria can develop from the environment, causing the drug to cloud, it is necessary to observe the following rules when opening the vial:

    - Wash hands thoroughly;

    - treat the cap with an alcohol-containing solution;

    - remove the cap without opening the plug;

    - Do not put a stopper on the inner surface of the table or other objects;

    - do not leave the vial open;

    - The opened vial should be stored only in the refrigerator.

    When using small doses (2-8 drops) the drug should be taken with a sterile syringe in a volume of 0.5-1 ml.

    The preparation from the opened bottle under observance of storage conditions, the above rules and absence of turbidity can be used during the whole shelf life.

    Side effects:
    Children of the first months of life in the first two days of taking the drug are possible regurgitation, rashes on the skin.

    Overdose:Not installed.
    Interaction:
    The use of the drug is possible in combination with other drugs, including antibiotics.


    Effect on the ability to drive transp. cf. and fur:None.
    Form release / dosage:
    Solution for oral and rectal administration.
    Packaging:
    Solution for oral administration and rectal administration in vials of 20 or 100 ml. For 4 or 10 bottles of 20 ml or 1 bottle of 100 ml with instructions for use in a pack of cardboard.

    Storage conditions:The preparation is stored in accordance with SP 3.3.2.1248-03 in a place protected from light and inaccessible to children at a temperature of 2 to 8 ° C.

    Transportation conditions. In accordance with SP 3.3.2.1248-03 at a temperature of 2 to 8 ° C. Transportation at a temperature of 8 to 25 ° C is allowed for not more than 1 month.
    Shelf life:
    Shelf life 2 years. The drug with expired shelf life is not subject to application.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-001999
    Date of registration:25.10.2011/11.11.2013
    The owner of the registration certificate:MICROGEN FGUP Scientific and Production Association MICROGEN FGUP Scientific and Production Association Russia
    Manufacturer: & nbsp
    Information update date: & nbsp17.03.2016
    Illustrated instructions
      Instructions
      Up